窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 16 2026

Full Issue

HHS Hires Economic Adviser To Oversee Health Care Affordability

The newly appointed chief economist and chief regulatory officer, Casey Mulligan, served on the Council of Economic Advisers during the previous Trump administration. This comes ahead of the midterms, as voters continue to express concern over health care costs, Axios reports.

The Trump administration is bringing on a new official to focus on health care affordability, the Department of Health and Human Services tells Axios. The personnel move suggests the administration is attempting to respond to voters' concerns about health care costs ahead of the midterm elections. (Owens, 4/16)

More on the high cost of health care

Baylor Scott & White Health Plan is quitting Medicaid and the health insurance exchange, the company announced Tuesday. The insurance division of the Dallas-based health system Baylor Scott & White Health notified members and Texas regulators it would leave the Medicaid managed care program on Aug. 31 and shut down its individual exchange operations at the end of the year. (Tong, 4/15)

Colorado Access President and CEO Annie Lee knows its a strange time to enter the health insurance exchanges. The expiration of enhanced subsidies combined with unexpectedly high medical costs and uncertainty over how President Donald Trumps administration will reshape the Affordable Care Act of 2010 marketplaces hasnt exactly attracted insurers, she said. CVS Health subsidiary Aetna notably exited the market last year, for example. Things have become more volatile. Theres not a financial draw, Lee said. (Tepper, 4/15)

Gov. Ned Lamont has got a sweet deal for Connecticut small businesses struggling to provide health insurance coverage to their employees. (Golvala, 4/15)

For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense. The CEO of the Philadelphia-based nonprofit hospital system Jefferson said his organization now spends more on prescription drug coverage fueled by the soaring use of weight loss medications like Wegovy and Zepbound than it does on inpatient care. (Lovelace Jr., Herzberg and Thompson, 4/16)

Hospital merger and acquisition activity has ramped up as health systems brace for financial pressure from shifting federal policies. Health systems proposed 22 hospital mergers and acquisitions in the first quarter, up from five in the first quarter of 2025 and nearing pre-pandemic levels of deal activity, according to data from consultancy Kaufman Hall. Executives have inked more merger and acquisition agreements this year following a historically slow 2025, and advisers expect the momentum to continue for the rest of the year. (Kacik, 4/15)

The Centers for Medicare and Medicaid Services is proposing to repeal a pathway that currently allows breakthrough devices to qualify for supplementary payments without proving they provide a substantial clinical improvement over alternatives. (Palmer, 4/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF